Association between low-density cholesterol change and outcomes in acute ischemic stroke patients who underwent

Ting Cui1, Changyi Wang1,2, Qiange Zhu3

  • 1Center of Cerebrovascular Diseases, Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Sichuan, 610041, Chengdu, China.

BMC Neurology
|September 17, 2021
PubMed

Insights

A drop in low-density lipoprotein cholesterol (LDL-C) during hospitalization is linked to worse outcomes for acute ischemic stroke (AIS) patients receiving reperfusion therapy. This finding highlights the importance of monitoring LDL-C changes post-stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Biochemistry

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a known cardiovascular risk factor.
  • The relationship between LDL-C fluctuations and functional recovery in acute ischemic stroke (AIS) patients undergoing reperfusion therapy requires further investigation.

Purpose of the Study:

  • To investigate the association between changes in LDL-C levels during hospitalization and functional outcomes at 90 days in AIS patients treated with reperfusion therapy.

Main Methods:

  • Consecutive enrollment of patients receiving reperfusion therapy.
  • LDL-C measurements taken at admission and during hospitalization.
  • Calculation of LDL-C change (ΔLDL-C) from admission to lowest inpatient level.
  • Assessment of functional outcome using modified Rankin Scale (mRS) at 90 days.

Main Results:

  • A total of 432 patients were analyzed.
  • No significant association was found between admission LDL-C and functional outcome.
  • A positive association was observed between ΔLDL-C and poor functional outcome (OR 1.80, 95% CI 1.12-2.91, p=0.016).
  • Patients in the highest tertile of ΔLDL-C showed significantly higher odds of poor functional outcomes (OR 2.56, 95% CI 1.22-5.36, p=0.013).

Conclusions:

  • A decrease in LDL-C levels during hospitalization is significantly associated with poor functional outcomes at 90 days in AIS patients who received reperfusion therapy.
  • Monitoring LDL-C dynamics may be crucial for predicting stroke recovery.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
67
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
350
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
968
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53